Curve Therapeutics

United Kingdom
Southampton, England, United Kingdom, SO17 1BJ

Company profile

Curve Therapeutics company profile

Curve has developed an innovative screening platform that is transforming the discovery of first-in-class therapeutics. The platform allows functional screening of diverse, genetically encoded Microcycle™ libraries against a broad range of disease-associated targets that are present in their native conformation inside a mammalian cell. Curve is deploying this platform to build a pipeline of novel cancer drugs.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Founded
2019-01-01, Year

Headquarters

Postal code
SO17 1BJ
Country code
GB
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
1
Total equity funding
$51.4M
Last funding
Series A / $51.4M / 2024-02-27
Last equity funding
Series A / $51.4M
Investors
5
Lead investors
1
Articles
34

Founders and investors

Lead investors

Pfizer Venture Investments

Investors

Advent Life SciencesBritish Patient CapitalColumbus Venture PartnersEpidarex CapitalPfizer Venture Investments